BIO News
Bio-Rad Laboratories, Inc.
$374.50
-$11.50(-2.98%)
55
Overall
60
Value
63
Tech
44
Quality
Market Cap
$10.07B
Volume
53.21K
52W Range
$236.73 - $396.23
Target Price
$390.33
BIO news: the latest Bio-Rad Laboratories, Inc. headlines, press releases and market updates, newest first.
Latest BIO News
- Jade Biosciences Updates Early JADE101 Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
- Doğanlar Yatırım Holding’s Biotrend Stake Reaches 50.13%TipRanks Turkey Auto-Generated Newsdesk · Nov 12, 2026
- Bio-Rad Laboratories Earnings Call Signals Cautious RecoveryTipRanks Auto-Generated Newsdesk · Nov 12, 2026
- Capital Markets Board Decision Covers Albaraka Türk Share StatusTipRanks Turkey Auto-Generated Newsdesk · Nov 11, 2026
- Doğanlar Yatırım Holding Discloses Biotrend Share PurchaseTipRanks Turkey Auto-Generated Newsdesk · Nov 11, 2026
- Biotrend Reports Consolidated Results for Period Ended September 30, 2026TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- BIotrend Cevre ve EnerjI Yatirimlari AS Discloses 2026 Interim Operating ReviewTipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Biotrend Responsibility Statement Covers Consolidated Financial StatementsTipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Zenas BioPharma, Inc. (ZBIO) Gets a Buy from GuggenheimTipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), COMPASS Pathways (CMPS) and Zenas BioPharma, Inc. (ZBIO)TipRanks Newsroom · Nov 9, 2026
- Doğanlar Holding Raises Biotrend Stake to 49.80%TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- Biome Signs Exclusive China Distribution AgreementTipRanks Australian Auto-Generated Newsdesk · Nov 8, 2026
- Biomm Announces Temporary Board Leadership ChangesTipRanks Brazil Auto-Generated Newsdesk · Nov 6, 2026
- Zenas BioPharma Launches New $200 Million Stock OfferingTipRanks Auto-Generated Newsdesk · Nov 6, 2026
- Sabio Holdings Announces Director ResignationTipRanks Canadian Auto-Generated Newsdesk · Nov 6, 2026
- Doğanlar Holding Raises Biotrend Stake to 49.67%TipRanks Turkey Auto-Generated Newsdesk · Nov 5, 2026
- Bio-Rad Reports Third-Quarter Results and Improved ProfitabilityTipRanks Auto-Generated Newsdesk · Nov 4, 2026
- Doğanlar Holding Raises Biotrend Stake to 49.63%TipRanks Turkey Auto-Generated Newsdesk · Nov 4, 2026
- Doğanlar Holding Raises Biotrend Stake to 49.11%TipRanks Turkey Auto-Generated Newsdesk · Nov 3, 2026
- Barclays Keeps Their Buy Rating on BridgeBio Pharma (BBIO)TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIO | $374.50 | -3.0% | 53.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bio-Rad Laboratories, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW